StockWatch
·

ASTRAZENECA PHARMA INDIA LTD. Q3 FY26 Results

ASTRAZENQ3 FY26 Results
Filing
MetricValue ( Cr)Q2 FY26Q3 FY25
Revenue611.579.4%38.9%
Total Income616.709.1%37.6%
Expenditure571.6417.3%53.4%
PBT46.5436.1%10.8%
Net Profit32.5939.9%5.6%
OPM7.57%4.93pp1.97pp
NPM5.28%4.31pp1.60pp
EPS13.0439.9%5.7%
View full financials

Informational and educational content only. Not investment advice.